Currently out of the existing stock ratings of Andrew Peters, 31 are a BUY (96.88%), 1 are a HOLD (3.13%).

Andrew Peters

Work Performance Price Targets & Ratings Chart

Analyst Andrew Peters works with a stock forecast success ratio of 86.75% fulfilled within 658.11 days on average. Previously, Andrew Peters worked at DEUTSCHE BANK, UBS.

Andrew Peters’s has documented 77 price targets and ratings displayed on 9 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ESPR, Esperion Therapeutics at 03-May-2018.

Wall Street Analyst Andrew Peters

Analyst best performing recommendations are on EXEL (EXELIXIS).
The best stock recommendation documented was for HALO (HALOZYME THERAPEUTICS) at 11/3/2016. The price target of $12 was fulfilled within 7 days with a profit of $3.54 (41.84%) receiving and performance score of 59.78.

Average potential price target upside

BMRN Biomarin Pharmaceutical GILD Gilead Sciences HALO Halozyme Therapeutics NBIX Neurocrine Biosciences ACHN Achillion Pharmaceuticals ALXN Alexion Pharmaceuticals ESPR Esperion Therapeutics PRTA Prothena plc EXEL Exelixis

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

100

$8.76 (9.60%)

100

3 days ago

1/6 (16.67%)

$8.76 (9.60%)

41

Buy

107

$15.76 (17.27%)

115

3 days ago

15/33 (45.45%)

$15.76 (17.27%)

391

Buy

104

$12.76 (13.99%)

127

27 days ago

1/4 (25%)

$14.38 (16.05%)

415

Buy

100

$8.76 (9.60%)

102

3 months 23 days ago

1/4 (25%)

$20.41 (25.64%)

22

Buy

117

$25.76 (28.23%)

125

3 months 24 days ago

12/17 (70.59%)

$37.33 (46.86%)

248

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Andrew Peters?

On 2010

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?